Clinical Trial

T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas

Name: T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas — clinical trial record (NCT07447531)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This clinical trial studies whether T2 star (T2\*) magnetic resonance imaging (MRI) and biomarker blood testing can help predict how World Health Organization (WHO) grade IV gliomas (malignant gliomas) might change or progress over time.

Trial Details

NCT Number	NCT07447531
Lead Sponsor	John M. Buatti
Conditions	Malignant Glioma
Enrollment	15 participants
Start Date	2025-10-03
Primary Completion	2028-10-06 (estimated)
Study Completion	2028-10-06 (estimated)
Updated on ClinicalTrials.gov	2026-03-03